Delaware Imaging Network Adds Breast Cancer Risk Scores During Annual Screening Mammograms, Paving Way for Personalized Breas...
June 21 2019 - 10:00AM
Delaware Imaging Network (DIN) has announced personalized breast
cancer risk assessment during annual mammographic screenings.
DIN, a wholly owned subsidiary of RadNet, Inc. (NASDAQ:
RDNT), was established in 2018 with the merger of Papastavros’
Associates Medical Imaging and Diagnostic Imaging Associates.
RadNet is a national market leader providing high-quality,
cost-effective diagnostic imaging services through a network of
fully-owned and operated outpatient imaging centers.
Dr. Jacqueline Holt, a breast specialist and the Medical
Director of Women’s Imaging at DIN, called the assessment “a free
service which supports our commitment to help women in Delaware
manage their breast health in the best possible way.”
“Breast cancer risk assessments are supported by guidelines from
NCCN, ACS, ACR, SBI, ASBrS, and others,” she said. “Paired with
information about a patient’s breast density, risk assessments
offer a powerful clinical tool to help patients, their referring
physicians, and their insurance providers navigate the appropriate
care pathways.”
“Many women are unaware that they are at above-average risk for
developing breast cancer and often underutilize resources,” said
Dr. Mireille Aujero, the Director of Breast Imaging with the
Delaware Imaging Network. “A risk assessment tool will help
referring providers identify these women at risk and personalize
screening options.”
Risk-based recommendations for supplemental screenings used by
DIN are derived from recommendations from the American Cancer
Society, the American College of Radiology, and the newly published
screening guidelines from the American Society of Breast Surgeons.
The risk assessment tool is the most updated version of the
Tyrer-Cuzick model (version 8), which is the most comprehensive and
validated tool available; its most recent version includes breast
density.
DIN’s board-certified and dedicated breast specialists, Dr. Holt
and Dr. Aujero, have published breast cancer-related research,
including research on 3D mammography and MRI, in the journals of
Radiology, Radiographics, and JAMA. Both radiologists have an
extensive background in 3D mammography, breast MRI, breast
ultrasound, and multi-modality breast biopsies.
About Delaware Imaging Network
With 12 locations in New Castle County, Del., Delaware Imaging
Network (DIN) was formed in August 2018 from the merger of
Papastavros’ Associates Medical Imaging and Diagnostic Imaging
Associates to provide the Delaware community with greater access to
high-quality, consumer-focused healthcare at lower costs than
hospital-owned radiology centers. An affiliated professional
practice of RadNet, Delaware Imaging Network offers the full range
of state-of-the-art outpatient radiology services. For more
information, visit http://delawareimagingnetwork.com.
About RadNet, Inc.
RadNet, Inc. is the leading national provider of freestanding,
fixed-site diagnostic imaging services in the United States based
on the number of locations and annual imaging revenue. RadNet has a
network of 335 owned and/or operated outpatient imaging centers.
RadNet's core markets include California, Florida, Maryland,
Delaware, New Jersey, and New York. In addition, RadNet provides
radiology information technology solutions, teleradiology
professional services and other related products and services to
customers in the diagnostic imaging industry. Together with
affiliated radiologists, and inclusive of full-time and per diem
employees and technicians, RadNet has a total of approximately
7,800 employees. For more information, visit
https://www.radnet.com.
CONTACT:Kenneth E.
AmesKenny.Ames@radnet.com(443) 223-9389
RadNet (NASDAQ:RDNT)
Historical Stock Chart
From Aug 2024 to Sep 2024
RadNet (NASDAQ:RDNT)
Historical Stock Chart
From Sep 2023 to Sep 2024